# FDA Inspection 1193101 - Sentara Infusion Services - December 16, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/sentara-infusion-services/8c23963a-af93-4502-9951-7946cec0b8cb/
Source feed: FDA_Inspections

> FDA Inspection 1193101 for Sentara Infusion Services on December 16, 2022. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1193101
- Company Name: Sentara Infusion Services
- Inspection Date: 2022-12-16
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1064475 - 2018-08-06](https://www.globalkeysolutions.net/api/records/fda_inspections/sentara-infusion-services/1244f8ac-1857-4dfd-997a-2527fcb9cc08/)
- [FDA Inspection 936197 - 2015-07-23](https://www.globalkeysolutions.net/api/records/fda_inspections/sentara-infusion-services/42648017-9c24-41da-8ea8-ef5af02a5b2b/)

Company: https://www.globalkeysolutions.net/companies/sentara-infusion-services/96cac868-e9c3-442c-883e-d92b5ac0fd49

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c